400 related articles for article (PubMed ID: 19650170)
41. Subclavicular recurrence of breast cancer: does surgery play a role?
Veronesi G; Scanagatta P; Leo F; Petrella F; Galetta D; Gasparri R; Borri A; Pelosi G; Leon ME; Spaggiari L
Breast; 2006 Oct; 15(5):649-53. PubMed ID: 16621560
[TBL] [Abstract][Full Text] [Related]
42. A case of heterogeneous breast cancer with clonally expanded T-Cells in the HER2+ and metastasis of the HER2- tumor cells.
Wiech T; Nikolopoulos E; Hausmann M; Walch A; Werner M; Fisch P
Breast J; 2008; 14(5):487-91. PubMed ID: 18821935
[TBL] [Abstract][Full Text] [Related]
43. Patterns of skin metastases: a review of 25 years' experience at a single cancer center.
Wong CY; Helm MA; Helm TN; Zeitouni N
Int J Dermatol; 2014 Jan; 53(1):56-60. PubMed ID: 23432658
[TBL] [Abstract][Full Text] [Related]
44. HER-2 protein overexpression in metastatic breast carcinoma found at autopsy.
Kyoda S; Kinoshita S; Takeyama H; Uchida K; Morikawa T
Jpn J Clin Oncol; 2008 Nov; 38(11):743-7. PubMed ID: 18836203
[TBL] [Abstract][Full Text] [Related]
45. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
46. Temporal and gender-related trends in brain metastases from lung and breast cancer.
Yawn BP; Wollan PC; Schroeder C; Gazzuola L; Mehta M
Minn Med; 2003 Dec; 86(12):32-7. PubMed ID: 14719614
[TBL] [Abstract][Full Text] [Related]
47. Effect of high copy number of HER2 associated with polysomy 17 on HER2 protein expression in invasive breast carcinoma.
Shah SS; Wang Y; Tull J; Zhang S
Diagn Mol Pathol; 2009 Mar; 18(1):30-3. PubMed ID: 19214111
[TBL] [Abstract][Full Text] [Related]
48. [Brain metastasis of breast tumors and blood brain barrier].
Diéras V; Pierga JY
Bull Cancer; 2011 Apr; 98(4):385-9. PubMed ID: 21527366
[TBL] [Abstract][Full Text] [Related]
49. High risk factors of brain metastases in 295 patients with advanced breast cancer.
Yan M; Lü HM; Liu ZZ; Liu H; Zhang MW; Sun XB; Cui SD
Chin Med J (Engl); 2013 Apr; 126(7):1269-75. PubMed ID: 23557557
[TBL] [Abstract][Full Text] [Related]
50. Treatment of pregnancy-associated breast cancer.
Janni W; Hepp P; Nestle-Kraemling C; Salmen J; Rack B; Genss E; Schindlbeck C; Friese K
Expert Opin Pharmacother; 2009 Oct; 10(14):2259-67. PubMed ID: 19663633
[TBL] [Abstract][Full Text] [Related]
51. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
[TBL] [Abstract][Full Text] [Related]
52. [Epidemiology of brain metastases].
Kehrli P
Neurochirurgie; 1999 Dec; 45(5):357-63. PubMed ID: 10717583
[TBL] [Abstract][Full Text] [Related]
53. Brain metastases: the HER2 paradigm.
Lin NU; Winer EP
Clin Cancer Res; 2007 Mar; 13(6):1648-55. PubMed ID: 17363517
[TBL] [Abstract][Full Text] [Related]
54. Solitary peritoneal metastases from ductal breast cancer.
D'Annibale M; Esposito A; Boschetto A; Marandino F; Lonardo MT; Vennarecci G
Chir Ital; 2007; 59(2):191-6. PubMed ID: 17500175
[TBL] [Abstract][Full Text] [Related]
55. The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases.
Dong R; Ji J; Liu H; He X
Crit Rev Oncol Hematol; 2019 Nov; 143():20-26. PubMed ID: 31449983
[TBL] [Abstract][Full Text] [Related]
56. Prophylactic cranial irradiation in advanced breast cancer: a case for caution.
Huang F; Alrefae M; Langleben A; Roberge D
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):752-8. PubMed ID: 18954943
[TBL] [Abstract][Full Text] [Related]
57. Carcinoid tumorlets simulate pulmonary metastases in women with breast cancer.
Darvishian F; Ginsberg MS; Klimstra DS; Brogi E
Hum Pathol; 2006 Jul; 37(7):839-44. PubMed ID: 16784983
[TBL] [Abstract][Full Text] [Related]
58. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision.
Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E
Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181
[TBL] [Abstract][Full Text] [Related]
59. Angiogenesis and co-expressed of ER and c-erbB-2 (HER2/neu) protein in primary breast cancer patients: an analysis of 158 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2008; 49(4):469-78. PubMed ID: 19050794
[TBL] [Abstract][Full Text] [Related]
60. Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.
Tuthill M; Pell R; Guiliani R; Lim A; Gudi M; Contractor KB; Lewis JS; Coombes RC; Stebbing J
Eur J Cancer; 2009 Aug; 45(12):2146-9. PubMed ID: 19464163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
